RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arovella Therapeutics - Stock

Arovella Therapeutics Net Income 2024

Arovella Therapeutics Net Income

-10.61 M AUD

Ticker

ALA.AX

ISIN

AU0000182784

WKN

A3C575

In 2024, Arovella Therapeutics's profit amounted to -10.61 M AUD, a 4.22% increase from the -10.18 M AUD profit recorded in the previous year.

The Arovella Therapeutics Net Income history

YEARNET INCOME (undefined AUD)
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-

Arovella Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Arovella Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Arovella Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Arovella Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Arovella Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Arovella Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Arovella Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Arovella Therapeutics’s growth potential.

Arovella Therapeutics Revenue, Profit, and EBIT History

DateArovella Therapeutics RevenueArovella Therapeutics EBITArovella Therapeutics Net Income
2025e0 AUD-10.77 M AUD-10.61 M AUD
2024e0 AUD-9.28 M AUD-10.61 M AUD
2023435,920 AUD-9.65 M AUD-10.18 M AUD
2022299,660 AUD-7.59 M AUD-8.62 M AUD
2021263,890 AUD-4.66 M AUD-5.05 M AUD
2020576,200 AUD-4.75 M AUD-9.94 M AUD
20191.25 M AUD-2.32 M AUD-7.8 M AUD
2018428,390 AUD-2.49 M AUD-5.46 M AUD
2017467,760 AUD-1.57 M AUD-1.24 M AUD
20165.87 M AUD-2.92 M AUD-2.29 M AUD

Arovella Therapeutics stock margins

The Arovella Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Arovella Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Arovella Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Arovella Therapeutics's sales revenue. A higher gross margin percentage indicates that the Arovella Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Arovella Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Arovella Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Arovella Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Arovella Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Arovella Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Arovella Therapeutics Margin History

Arovella Therapeutics Gross marginArovella Therapeutics Profit marginArovella Therapeutics EBIT marginArovella Therapeutics Profit margin
2025e53.31 %0 %0 %
2024e53.31 %0 %0 %
202353.31 %-2,213.87 %-2,335.6 %
202230.9 %-2,533.73 %-2,876.79 %
202115.59 %-1,765.72 %-1,912.72 %
202065.12 %-824.7 %-1,724.33 %
201984.02 %-186.01 %-623.66 %
201856.67 %-581.63 %-1,274.37 %
201787.82 %-334.98 %-264.73 %
201614.08 %-49.69 %-38.95 %

Arovella Therapeutics Aktienanalyse

What does Arovella Therapeutics do?

Arovella Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Arovella Therapeutics's Profit Margins

The profit margins of Arovella Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Arovella Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Arovella Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Arovella Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Arovella Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Arovella Therapeutics Stock

How much profit has Arovella Therapeutics made this year?

Arovella Therapeutics has made -10.61 M AUD this year.

How has the profit developed compared to last year?

The profit has increased by 4.22% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Arovella Therapeutics publish its earnings?

Arovella Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Arovella Therapeutics?

The profits of Arovella Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Arovella Therapeutics?

You can learn more about the earnings of Arovella Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Arovella Therapeutics pay?

Over the past 12 months, Arovella Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arovella Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Arovella Therapeutics?

The current dividend yield of Arovella Therapeutics is .

When does Arovella Therapeutics pay dividends?

Arovella Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arovella Therapeutics?

Arovella Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Arovella Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arovella Therapeutics located?

Arovella Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arovella Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arovella Therapeutics from 6/21/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did Arovella Therapeutics pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of Arovella Therapeutics in the year 2023?

In the year 2023, Arovella Therapeutics distributed 0 AUD as dividends.

In which currency does Arovella Therapeutics pay out the dividend?

The dividends of Arovella Therapeutics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arovella Therapeutics

Our stock analysis for Arovella Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arovella Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.